ELDN icon

Eledon Pharmaceuticals
ELDN

Overview Fund Activity

29 hedge funds and large institutions have $19.8M invested in Eledon Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 8 increasing their positions, 9 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
29
Holders Change
–
Holders Change %
0%
% of All Funds
0.42%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
8
Reduced
9
Closed
3
Calls
$4K
Puts
$3K
Net Calls
+$1K
Net Calls Change
–

Top Buyers

1
Vanguard Group
1
Vanguard Group
Pennsylvania
$2M
2
AC
2
Armistice Capital
New York
$4.73M
3
SSA
3
Schonfeld Strategic Advisors
New York
$105K
4
MIM
4
Marco Investment Management
Georgia
$51.1K
5
CM
5
CM Management
Florida
$330K

Top Sellers

1
WP
1
Woodline Partners
California
$1.34M
2
TSS
2
Two Sigma Securities
New York
$0
3
Millennium Management
3
Millennium Management
New York
$28.6K
4
Citadel Advisors
4
Citadel Advisors
Florida
$32.9K
5
Simplex Trading
5
Simplex Trading
Illinois
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Group One Trading
26
Group One Trading
Illinois
$45 – – –
Fidelity Investments
27
Fidelity Investments
Massachusetts
$35 +$35 +17 New
UBS Group
28
UBS Group
Switzerland
$8 -$1.1K -552 -99%
TSS
29
Two Sigma Securities
New York
– -$21.2K -11,780 Closed
Simplex Trading
30
Simplex Trading
Illinois
– -$5K -3,223 Closed
Bank of America
31
Bank of America
North Carolina
– -$27 -15 Closed
1
2